This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): PD-0200390, atagabalin
Description: PD-200,390 binds to the alpha-2-delta binding site, an auxiliary subunit of voltage-gated calcium channels. This site is thought to be responsible for the action of drugs such as Lyrica and Neurontin, which are used to treat epilepsy and neuropathic pain.
Pink Sheet Weekly Trademark Review Sept. 1, 2015
Additional information available to subscribers only: